News Headlines Article

Lawmakers, Candidates Target High Drug Prices
The Wall Street Journal

Lawmakers and the Obama administration are ratcheting up efforts to target pharmaceutical companies over high-priced drugs, a sign that legislators are trying to bridge partisan differences to tackle a key driver of rising health care costs.

Some specialty drugs can now run $100,000 or more a year, and the issue has been amplified by several high-profile cases in which makers boosted prices dramatically and rapidly.

The Health and Human Services Department is considering new steps to protect consumers, while lawmakers are launching a task force to probe the issue and presidential candidates from both parties are criticizing drug makers.